| Product Name | MF | CAS | Details |
|---|
| EBOV-IN-7 | C18H19ClN4O3S | 68207-16-9 | Details |
| CDK8-IN-14 | C18H13N3O2 | 2924193-12-2 | Details |
| BChE-IN-25 | C17H23NO2 | 79183-25-8 | Details |
| ATF4-IN-1 | C24H21Cl2N3O4 | 2991057-76-0 | Details |
| Antitumor agent-100 | C17H14ClN3O | 2841750-32-9 | Details |
| Anti-osteoporosis agent-3 | 2944463-16-3 | Details |
| Antitumor agent-138 | C20H21N3O4 | 2975168-22-8 | Details |
| ATAD2-IN-1 | C22H26N6O5 | 3004556-06-0 | Details |
| Antifungal agent 100 | C23H21N3O4S | 2975157-18-5 | Details |
| Antibacterial agent 172 | C21H21N9O5S2 | 3023114-93-1 | Details |
| Antitumor agent-144 | C25H26N4O4 | 137346-42-0 | Details |
| BIO-7488 | C23H25N7O3 | 2573211-25-1 | Details |
| BET-IN-20 | 1300735-76-5 | Details |
| EBOV-IN-3 | C21H28N2O4S2 | 2896193-40-9 | Details |
| CYP4A11/CYP4F2-IN-2 | 2280834-99-1 | Details |
| COX-2-IN-40 | C19H11ClO3 | 444790-64-1 | Details |
| CTSL/CAPN1-IN-2 | C34H40N4O6 | 2410075-64-6 | Details |
| BAY-155 | C28H28F3N7OS | 2163769-52-4 | Details |
| AS115 | C21H32FNO4 | 926657-43-4 | Details |
| DNMT-IN-3 | C37H39N7O | 1683516-27-9 | Details |
| DNMT/HDAC-IN-1 | 2095619-17-1 | Details |
| DCLK1-IN-5 | C26H32ClN7O3S2 | 3028774-14-0 | Details |
| DHODH-IN-24 | C26H26N4 | 418775-30-1 | Details |
| CSF1R-IN-22 | C20H20N6O3 | 2760585-35-9 | Details |
| COX-2-IN-43 | C18H11Cl2F3N2O3 | 1023524-40-4 | Details |
| CXF-007 | C34H33N7O5 | 2727083-99-8 | Details |
| CDK2-IN-23 | C20H27F3N6O3S | 2488073-20-5 | Details |
| CVM-05-002 | C16H14N4O3S2 | 2428738-43-4 | Details |
| TM38837 | C27H20Cl2F3N7O | 1034264-77-1 | Details |
| BET-IN-23 | C29H34FN3O5 | 2953287-57-3 | Details |
| Atrazine-3-mercaptopropanoic acid | C11H19N5O2S | 125454-31-1 | Details |
| CRT0066101 | C18H22N6O | 956123-34-5 | Details |
| CSF1R-IN-21 | C24H20F3N5O3 | 2935479-62-0 | Details |
| CBR1-IN-4 | C17H13ClN2O3 | 1798284-64-6 | Details |
| ChEs/MAOs-IN-2 | C15H12N2O3S | 693268-77-8 | Details |
| COX-1-IN-1 | C20H21NO3 | 1369503-03-6 | Details |
| CEP-28122 mesylate hydrochloride | C29H40Cl2N6O6S | 1354545-57-5 | Details |
| CBR1-IN-7 | C22H22O13 | 1119826-35-5 | Details |
| CHI3L1-IN-1 | C22H27Cl2N3O | 2982256-78-8 | Details |
| CB7993113 | C15H10BrNO5 | 819827-50-4 | Details |
| CZL80 | C19H14N2O4S | 313482-91-6 | Details |
| DPP-4-IN-9 | C28H23N5O4 | 2906243-39-6 | Details |
| BChE-IN-23 | C20H19FN2O | 2020357-32-6 | Details |
| CVN766 | C20H21F3N8O | 1803557-42-7 | Details |
| CSF1R-IN-20 | C25H26F3N5O3 | 2935479-57-3 | Details |
| CDK2-IN-27 | C18H21N7O2 | 2927473-94-5 | Details |
| DHX9-IN-5 | C23H24ClN5O4S | 2973398-17-1 | Details |
| Divarasib adipate | 2762240-36-6 | Details |
| Antiproliferative agent-22 | C17H13N3O3 | 1374305-45-9 | Details |
| COX-2-IN-39 | C17H17N3O3S2 | 1018480-89-1 | Details |
| Antibacterial agent 169 | 2879255-03-3 | Details |
| Calcium mesoxalate | C6H6CaO12 | 21085-60-9 | Details |
| CHI3L1-IN-2 | C26H37ClN4 | 2982257-63-4 | Details |
| Dopamine D4 receptor ligand 2 | C20H24ClN3O2 | 219125-63-0 | Details |
| AR antagonist 5 | C23H21F3N6O2 | 2902679-53-0 | Details |
| BRD4 Inhibitor-30 | C28H38N6O4 | 1789731-20-9 | Details |
| CCR8 antagonist 3 | C29H33N3O4 | 912463-57-1 | Details |
| BAY-5516 | C23H17ClF4N2O3 | 2891706-79-7 | Details |
| DU-14 | C22H38N2O4S | 186303-55-9 | Details |
| CSF1R-IN-23 | C27H37N3O2 | 2935480-17-2 | Details |
| Antifungal agent 87 | C14H14O4 | 692730-21-5 | Details |
| ASN02563583 | C25H24N4O3S | 483283-39-2 | Details |
| Anticancer agent 129 | C18H17N3 | 135882-37-0 | Details |
| Antidiabetic agent 5 | 2152667-21-3 | Details |
| Antiangiogenic agent 5 | C25H22F3N5O3 | 2095397-52-5 | Details |
| AQP3-IN-1 | C11H9AuCl2N2 | 198711-19-2 | Details |
| Anti-infective agent 9 | C14H11F3N4S2 | 758689-17-7 | Details |
| CYP19A1/CYP11B2-IN-1 | C12H11N3O | 183500-36-9 | Details |
| DPP1-IN-1 hydrate | C23H23FN4O4.H2O | 2971064-13-6 | Details |
| Aurora kinase inhibitor-11 | C11H10BrN3OS | 923946-98-9 | Details |
| BaENR-IN-1 | C12H8ClNO4 | 1071966-17-0 | Details |
| CD 10899 | C34H50N8O4 | 1331770-20-7 | Details |
| C3TD879 | C22H28N4O | 2850259-33-3 | Details |
| CXF-009 | C33H38N8O5 | 2727084-00-4 | Details |
| CDK2-IN-18 | 364735-73-9 | Details |
| cGAS-IN-2 | C16H18Cl2N2O2 | 2765273-11-6 | Details |
| COX-1/2-IN-6 | 327024-84-0 | Details |
| CBR1-IN-3 | C16H11ClN2O3 | 891101-69-2 | Details |
| BRD4 Inhibitor-29 | C21H28N2O3 | 902563-50-2 | Details |
| Casein kinase 1δ-IN-15 | C19H17FN6O | 2765264-27-3 | Details |
| CARM1-IN-4 | C24H42N2O4 | 2878481-07-1 | Details |
| BTL-MK | C24H24O6 | 2758569-43-4 | Details |
| CBR1-IN-5 | C17H13ClN2O3 | 1798284-62-4 | Details |
| AQIM-I | C17H13N2O2.I | 2247881-73-6 | Details |
| CTPS1-IN-2 | C24H27N7O5S | 2377000-84-3 | Details |
| DNA-PK-IN-12 | C21H24N8O2 | 2792146-91-7 | Details |
| Arginase inhibitor 7 | C14H29BN6O5 | 2377392-07-7 | Details |
| AR/AR-V7-IN-1 | C36H43ClFN7O2 | 2964558-54-9 | Details |
| c-Myc inhibitor 14 | C38H52BN3O7 | 2581994-88-7 | Details |
| DHODH-IN-25 | C22H19ClF5N3O5 | 2619531-95-0 | Details |
| Anticancer agent 183 | 3018960-58-9 | Details |
| CVN293 | C14H10FN7O | 2815296-08-1 | Details |
| DB18 | C24H18ClN7O3 | 2587177-94-2 | Details |
| DDABT1 | C40H34N4O4 | 2777045-35-7 | Details |
| Arfolitixorin sulfate | C20H25N7O10S | 149930-93-8 | Details |
| BAY-6096 | C21H23N6O2.Cl | 2313483-41-7 | Details |
| DS43260857 | C19H16F3N3O3S | 1612158-07-2 | Details |
| Antitumor agent-122 | 2378641-43-9 | Details |
| ATF4-IN-2 | C24H21BrClN5O4 | 2991057-60-2 | Details |
| BTK-IN-30 | C23H21F2N5O3 | 2662512-15-2 | Details |
| Product Total： Product Page： | ||||
| 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 | ||||